Company
Circular Genomics
Also known as Circular Genomics, Inc
- Business model
- B2B
- Legal name
- Circular Genomics, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Circular Genomics is a biotechnology and genomics company with a vision to use circular RNAs as novel and improved biomarkers for the diagnosis and better treatment of psychiatric and neurological diseases.
Funding snapshot
- Total raised
- $12.6MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $8.3M2024-01-11
Funding rounds
- Round, 2024
- $8.3M2024-01-11, SEC form D sold, 9 investors
- Round, 2021
- $3.1M2021-11-30, SEC form D sold, 7 investors
- Round, 2021
- $1.2M2021-08-05, SEC form D sold, 7 investors
Loading relationship preview